CONCERT PHARMACEUTICALS, INC. Annual General and Administrative Expense in USD from 2012 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2012 to 2021.
  • Concert Pharmaceuticals, Inc. General and Administrative Expense for the quarter ending September 30, 2022 was $5.25M, a 3.88% decline year-over-year.
  • Concert Pharmaceuticals, Inc. General and Administrative Expense for the twelve months ending September 30, 2022 was $21.6M, a 0.18% increase year-over-year.
  • Concert Pharmaceuticals, Inc. annual General and Administrative Expense for 2021 was $22.5M, a 19.1% increase from 2020.
  • Concert Pharmaceuticals, Inc. annual General and Administrative Expense for 2020 was $18.9M, a 6.66% decline from 2019.
  • Concert Pharmaceuticals, Inc. annual General and Administrative Expense for 2019 was $20.3M, a 11.6% decline from 2018.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $22.5M +$3.61M +19.1% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-03
2020 $18.9M -$1.35M -6.66% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $20.3M -$2.66M -11.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $22.9M +$1.92M +9.14% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $21M +$6.66M +46.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 $14.4M +$1.3M +9.97% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $13.1M +$1.36M +11.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $11.7M +$3.67M +45.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 $8.03M +$762K +10.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
2012 $7.27M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.